Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 9 | 2025 | 218 | 3.760 |
Why?
|
| Nanoparticles | 7 | 2023 | 460 | 2.520 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 1019 | 1.640 |
Why?
|
| Liposomes | 3 | 2023 | 132 | 1.300 |
Why?
|
| Fluorouracil | 4 | 2024 | 47 | 1.250 |
Why?
|
| Drug Delivery Systems | 4 | 2021 | 277 | 1.170 |
Why?
|
| Pyrimidine Nucleosides | 1 | 2024 | 9 | 0.840 |
Why?
|
| Blood-Brain Barrier | 4 | 2021 | 173 | 0.840 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2014 | 17 | 0.710 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 94 | 0.650 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2025 | 67 | 0.620 |
Why?
|
| Brain Ischemia | 1 | 2021 | 189 | 0.620 |
Why?
|
| Deoxycytidine | 3 | 2025 | 38 | 0.550 |
Why?
|
| Stroke | 1 | 2021 | 340 | 0.530 |
Why?
|
| Contrast Media | 1 | 2017 | 103 | 0.510 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 587 | 0.500 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 2676 | 0.470 |
Why?
|
| Mice | 7 | 2025 | 6644 | 0.440 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 512 | 0.440 |
Why?
|
| Gadolinium | 3 | 2023 | 30 | 0.430 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 1001 | 0.390 |
Why?
|
| Cell Proliferation | 3 | 2024 | 1455 | 0.370 |
Why?
|
| Animals | 9 | 2025 | 16992 | 0.360 |
Why?
|
| Nanostructures | 1 | 2014 | 161 | 0.360 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2023 | 347 | 0.330 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 129 | 0.300 |
Why?
|
| Amyloid | 1 | 2008 | 65 | 0.270 |
Why?
|
| Brain | 2 | 2021 | 1472 | 0.260 |
Why?
|
| Cachexia | 1 | 2025 | 7 | 0.240 |
Why?
|
| Organoids | 1 | 2025 | 37 | 0.230 |
Why?
|
| Pyrazoles | 1 | 2025 | 103 | 0.230 |
Why?
|
| Humans | 11 | 2025 | 43102 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 131 | 0.220 |
Why?
|
| Pyrimidines | 1 | 2025 | 139 | 0.220 |
Why?
|
| Apoptosis | 2 | 2022 | 1568 | 0.210 |
Why?
|
| Microsomes, Liver | 1 | 2024 | 75 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 220 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 307 | 0.190 |
Why?
|
| Tissue Distribution | 1 | 2023 | 240 | 0.190 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 53 | 0.180 |
Why?
|
| HCT116 Cells | 1 | 2020 | 40 | 0.170 |
Why?
|
| Cell Survival | 1 | 2024 | 945 | 0.160 |
Why?
|
| Quality of Life | 1 | 2025 | 616 | 0.160 |
Why?
|
| Mice, SCID | 1 | 2020 | 158 | 0.160 |
Why?
|
| Cattle | 2 | 2013 | 498 | 0.150 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 28 | 0.140 |
Why?
|
| Viscosity | 1 | 2017 | 46 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 95 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1596 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2017 | 141 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1621 | 0.130 |
Why?
|
| Particle Size | 1 | 2017 | 272 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2017 | 408 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 968 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 16 | 0.110 |
Why?
|
| Models, Biological | 1 | 2017 | 712 | 0.100 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 59 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 94 | 0.100 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2013 | 3 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 51 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 296 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2013 | 136 | 0.090 |
Why?
|
| Neoplasms | 1 | 2023 | 1377 | 0.090 |
Why?
|
| Cell Line | 1 | 2014 | 1410 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2013 | 329 | 0.080 |
Why?
|
| Inflammation | 1 | 2014 | 758 | 0.070 |
Why?
|
| Chitosan | 1 | 2008 | 53 | 0.070 |
Why?
|
| Pyrimidinones | 1 | 2025 | 15 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2025 | 39 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2025 | 187 | 0.050 |
Why?
|
| Female | 2 | 2017 | 24698 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2023 | 67 | 0.050 |
Why?
|
| Universities | 1 | 2025 | 559 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 478 | 0.040 |
Why?
|
| California | 1 | 2023 | 548 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2025 | 502 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|